JP2009534332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009534332A5 JP2009534332A5 JP2009505767A JP2009505767A JP2009534332A5 JP 2009534332 A5 JP2009534332 A5 JP 2009534332A5 JP 2009505767 A JP2009505767 A JP 2009505767A JP 2009505767 A JP2009505767 A JP 2009505767A JP 2009534332 A5 JP2009534332 A5 JP 2009534332A5
- Authority
- JP
- Japan
- Prior art keywords
- hpv
- composition
- polypeptide
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06360014 | 2006-04-21 | ||
| PCT/EP2007/003368 WO2007121895A2 (en) | 2006-04-21 | 2007-04-17 | Hpv-16-based papillomavirus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009534332A JP2009534332A (ja) | 2009-09-24 |
| JP2009534332A5 true JP2009534332A5 (https=) | 2010-06-03 |
Family
ID=38362856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009505767A Withdrawn JP2009534332A (ja) | 2006-04-21 | 2007-04-17 | パピローマウイルスワクチン |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100061957A1 (https=) |
| EP (1) | EP2013230A2 (https=) |
| JP (1) | JP2009534332A (https=) |
| KR (1) | KR20090005011A (https=) |
| CN (1) | CN101426811A (https=) |
| AU (1) | AU2007241406A1 (https=) |
| BR (1) | BRPI0710238A2 (https=) |
| CA (1) | CA2649392A1 (https=) |
| IL (1) | IL193661A0 (https=) |
| MX (1) | MX2008013488A (https=) |
| NO (1) | NO20084857L (https=) |
| RU (1) | RU2008145712A (https=) |
| WO (1) | WO2007121895A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8877206B2 (en) | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
| US8926961B2 (en) * | 2007-10-03 | 2015-01-06 | Board Of Trustees Of The University Of Arkansas | HPV E6 protein T cell epitopes and uses thereof |
| CA2721366C (en) | 2008-04-17 | 2017-06-06 | Elizabeth Ann Vasievich | Stimulation of an immune response by enantiomers of cationic lipids |
| EP2239330A1 (en) | 2009-04-07 | 2010-10-13 | Institut Pasteur | Neuron generation, regeneration and protection |
| BR112013000912A2 (pt) * | 2010-07-15 | 2016-05-17 | British Columbia Cancer Agency | composições de antígeno e7 de papilomavírus humano e usos dos mesmos |
| CN102343103B (zh) * | 2011-07-26 | 2016-04-27 | 马丁 | 人乳头状瘤病毒16型三肽疫苗的筛选和验证及持续表达hpv16 e5, e6, e7的肿瘤动物模型的构建 |
| EP2601968A1 (en) * | 2011-12-06 | 2013-06-12 | Deutsches Krebsforschungszentrum | HPV derived polynucleic acids for therapy |
| CN105163753B (zh) | 2012-06-15 | 2018-12-21 | Pds生物科技公司 | 阳离子脂质疫苗组合物和使用方法 |
| CN105101991A (zh) | 2012-09-21 | 2015-11-25 | Pds生物科技公司 | 改进的疫苗组合物和使用方法 |
| US9000736B2 (en) | 2013-05-03 | 2015-04-07 | Cooper Technologies Company | Power factor correction algorithm for arbitrary input waveform |
| US9548794B2 (en) | 2013-05-03 | 2017-01-17 | Cooper Technologies Company | Power factor correction for constant current input with power line communication |
| US9190901B2 (en) | 2013-05-03 | 2015-11-17 | Cooper Technologies Company | Bridgeless boost power factor correction circuit for constant current input |
| US9214855B2 (en) | 2013-05-03 | 2015-12-15 | Cooper Technologies Company | Active power factor correction circuit for a constant current power converter |
| WO2017083820A1 (en) | 2015-11-13 | 2017-05-18 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
| KR20190033483A (ko) * | 2016-06-03 | 2019-03-29 | 이투빅스 코포레이션 | 인간 파필로마바이러스 (hpv)-연관 질환의 치료를 위한 조성물 및 방법 |
| SG11201902988UA (en) | 2016-10-05 | 2019-05-30 | Pds Biotechnology Corp | Novel hpv16 non hla-restricted t-cell vaccines, compositions and methods of use thereof |
| CA3084957A1 (en) | 2017-12-05 | 2019-06-13 | Pds Biotechnology Corporation | Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes |
| WO2020117715A1 (en) | 2018-12-03 | 2020-06-11 | Board Of Regents, The University Of Texas System | Oligo-benzamide analogs and their use in cancer treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
| FR2766091A1 (fr) * | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
| WO2002077012A2 (en) * | 2001-03-23 | 2002-10-03 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Human papilloma virus immunoreative peptides |
| DE60332377D1 (de) * | 2002-10-21 | 2010-06-10 | Eisai Inc | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden |
-
2007
- 2007-04-17 AU AU2007241406A patent/AU2007241406A1/en not_active Abandoned
- 2007-04-17 WO PCT/EP2007/003368 patent/WO2007121895A2/en not_active Ceased
- 2007-04-17 EP EP07724305A patent/EP2013230A2/en not_active Withdrawn
- 2007-04-17 CA CA002649392A patent/CA2649392A1/en not_active Abandoned
- 2007-04-17 US US12/297,977 patent/US20100061957A1/en not_active Abandoned
- 2007-04-17 MX MX2008013488A patent/MX2008013488A/es not_active Application Discontinuation
- 2007-04-17 KR KR1020087025575A patent/KR20090005011A/ko not_active Ceased
- 2007-04-17 CN CNA2007800143963A patent/CN101426811A/zh active Pending
- 2007-04-17 RU RU2008145712/13A patent/RU2008145712A/ru unknown
- 2007-04-17 JP JP2009505767A patent/JP2009534332A/ja not_active Withdrawn
- 2007-04-17 BR BRPI0710238-0A patent/BRPI0710238A2/pt not_active IP Right Cessation
-
2008
- 2008-08-25 IL IL193661A patent/IL193661A0/en unknown
- 2008-11-18 NO NO20084857A patent/NO20084857L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009534332A5 (https=) | ||
| JP2009534331A5 (https=) | ||
| RU2008145712A (ru) | Вакцина против папилломовирусной инфекции на основе вируса папиломы человека впч-16 | |
| IL215599A (en) | A nucleic acid-encoding vector for proteins 1e and 2e of the papilloma virus | |
| JP2010516287A5 (https=) | ||
| RU2009144898A (ru) | Векторы для множественной генной экспрессии | |
| JP2010526547A5 (https=) | ||
| US8147839B2 (en) | Fusion proteins of HIV regulatory/accessory proteins | |
| US20100055069A1 (en) | Hpv-18-based papillomavirus vaccines | |
| JP2018148890A5 (https=) | ||
| TR201900695T4 (en) | HPV / CYAA-BASED CHEMICAL PROTEINS AND THEIR USE IN INDUCING IMMUNE RESPONSE AGAINST HPV INFECTION AND HPV-INDUCED DISASTER. | |
| RU2008106481A (ru) | Композиция для лечения и предупреждения папилломавирусной инфекции человека на основе белка l1 и пептидов белка е7 |